Shanghai Xuerong Bio-Technology Co Ltd (300511) — Capital Reinvestment Ratio
Shanghai Xuerong Bio-Technology Co Ltd (300511) has a Capital Reinvestment Ratio of 0.31x as of September 2022, meaning it reinvests 0% of its operating cash flow (CN¥190.71 Million) in capital expenditures (CN¥58.20 Million). See Shanghai Xuerong Bio-Technology Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Xuerong Bio-Technology Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Shanghai Xuerong Bio-Technology Co Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see 300511 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.75x | CN¥437.20 Million | CN¥327.46 Million | ▼ -75.6% |
| 2023 | 3.07x | CN¥357.84 Million | CN¥1.10 Billion | ▲ +252.3% |
| 2022 | 0.87x | CN¥367.13 Million | CN¥319.47 Million | ▼ -66.4% |
| 2021 | 2.59x | CN¥246.75 Million | CN¥639.87 Million | ▲ +198.4% |
| 2020 | 0.87x | CN¥555.47 Million | CN¥482.79 Million | ▲ +63.3% |
| 2019 | 0.53x | CN¥586.93 Million | CN¥312.38 Million | ▼ -51.0% |
| 2018 | 1.09x | CN¥406.82 Million | CN¥442.23 Million | ▼ -69.7% |
| 2017 | 3.59x | CN¥328.64 Million | CN¥1.18 Billion | ▲ +63.9% |
| 2016 | 2.19x | CN¥317.71 Million | CN¥695.20 Million | ▲ +111.1% |
| 2015 | 1.04x | CN¥273.77 Million | CN¥283.78 Million | ▲ +61.0% |
| 2014 | 0.64x | CN¥253.24 Million | CN¥163.01 Million | ▼ -23.7% |
| 2013 | 0.84x | CN¥235.07 Million | CN¥198.39 Million | ▼ -83.1% |
| 2012 | 4.99x | CN¥112.14 Million | CN¥559.93 Million | — |